Cite

HARVARD Citation

    Zafar, Y. et al. (n.d.). PCSK9 Inhibitors Do Not Worsen Liver Function Tests in Patients With Hepatic Steatosis. American journal of gastroenterology. p. . [Online]. 
  
Back to record